<SEC-DOCUMENT>0000950103-25-013225.txt : 20251016
<SEC-HEADER>0000950103-25-013225.hdr.sgml : 20251016
<ACCEPTANCE-DATETIME>20251016101717
ACCESSION NUMBER:		0000950103-25-013225
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20251015
DATE AS OF CHANGE:		20251016

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BARCLAYS BANK PLC
		CENTRAL INDEX KEY:			0000312070
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-287303
		FILM NUMBER:		251396699

	BUSINESS ADDRESS:	
		STREET 1:		1 CHURCHILL PLACE
		STREET 2:		CANARY WHARF
		CITY:			LONDON
		STATE:			X0
		ZIP:			E14 5HP
		BUSINESS PHONE:		0044-20-3555-4619

	MAIL ADDRESS:	
		STREET 1:		1 CHURCHILL PLACE
		STREET 2:		CANARY WHARF
		CITY:			LONDON
		STATE:			X0
		ZIP:			E14 5HP

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BARCLAYS BANK PLC /ENG/
		DATE OF NAME CHANGE:	19990402

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BARCLAYS BANK INTERNATIONAL LTD
		DATE OF NAME CHANGE:	19850313
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp235891_424b2-7906barc.htm
<DESCRIPTION>FORM 424B2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: red"><B>The information in this preliminary pricing supplement
is not complete and may be changed. This preliminary pricing supplement and the accompanying prospectus, prospectus supplement and underlying
supplement do not constitute an offer to sell the Notes and we are not soliciting an offer to buy the Notes in any state where the offer
or sale is not permitted.</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: red">Subject to Completion</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: red"><B>Preliminary Pricing Supplement
dated October 15, 2025</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 79%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pricing Supplement dated October&nbsp;&nbsp;&nbsp;&nbsp;, 2025</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(To the Prospectus dated May 15, 2025, the Prospectus Supplement
dated May 15, 2025</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">and the Underlying Supplement dated May 15, 2025)</P></TD>
    <TD STYLE="width: 21%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Filed Pursuant to Rule 424(b)(2)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Registration No. 333-287303</P></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 20%; font-size: 12pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="image_001.jpg" ALT="barclays PLC logo" STYLE="height: 32px; width: 133px"></FONT></TD>
    <TD STYLE="vertical-align: top; width: 80%"><P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$&#9679;</FONT></P>
    <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Contingent
    Coupon Barrier Notes due November 3, 2028</FONT></P>
    <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Linked
    to the Lesser Performing of the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index</FONT></P>
    <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Global
    Medium-Term Notes<FONT STYLE="font-weight: normal">,</FONT> Series A</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Unlike ordinary debt securities, the Notes do not guarantee the payment
of interest or the return of the full principal amount at maturity. Instead, as described below, the Notes offer a Contingent Coupon
for each Observation Date on which the Closing Value of each Underlier is greater than or equal to its Coupon Barrier Value. Investors
should be willing to forgo dividend payments and, if the Final Underlier Value of any Underlier is less than its Barrier Value, be willing
to lose a significant portion or all of their investment at maturity. <B>Investors will be exposed to the market risk of each Underlier
and any decline in the value of one Underlier may negatively affect their return and will not be offset or mitigated by a lesser decline
or any potential increase in the value of the other Underlier.</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">KEY TERMS*</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Issuer:</FONT></TD>
    <TD STYLE="width: 85%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Barclays Bank PLC </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Denominations:</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Minimum denomination of $1,000, and integral multiples of $1,000 in excess thereof</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Initial Valuation Date:<SUP>&dagger;</SUP></FONT></TD>
    <TD STYLE="width: 30%; font-size: 10pt"><FONT STYLE="font-size: 10pt">October 31, 2025</FONT></TD>
    <TD STYLE="width: 18%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Final Valuation Date:<SUP>&dagger;</SUP></FONT></TD>
    <TD STYLE="width: 37%; font-size: 10pt"><FONT STYLE="font-size: 10pt">October 31, 2028</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Issue Date:</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">November 5, 2025</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Maturity Date:<SUP>&dagger;</SUP></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">November 3, 2028</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Reference Assets:</FONT></TD>
    <TD STYLE="width: 85%; font-size: 10pt; text-align: left; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The Russell 2000<SUP>&reg;</SUP> Index (the &ldquo;RTY Index&rdquo;) and the S&amp;P 500<SUP>&reg;</SUP> Index (the &ldquo;SPX Index&rdquo;) (each, an &ldquo;Underlier&rdquo; and together, the &ldquo;Underliers&rdquo;), as set forth in the following table:</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 15%; border-right: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 13%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #D9D9D9; text-align: center"><FONT STYLE="font-size: 10pt"><B>Underliers</B></FONT></TD>
    <TD STYLE="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #D9D9D9; text-align: center"><FONT STYLE="font-size: 10pt"><B>Bloomberg Ticker</B></FONT></TD>
    <TD STYLE="width: 21%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #D9D9D9; text-align: center"><FONT STYLE="font-size: 10pt"><B>Initial Underlier Value</B><SUP>(1)</SUP></FONT></TD>
    <TD STYLE="width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #D9D9D9; text-align: center"><FONT STYLE="font-size: 10pt"><B>Coupon Barrier Value</B><SUP>(2)</SUP></FONT></TD>
    <TD STYLE="width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #D9D9D9; text-align: center"><FONT STYLE="font-size: 10pt"><B>Barrier Value</B><SUP>(2)</SUP></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">RTY Index</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">RTY&lt;Index&gt;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">SPX Index</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">SPX&lt;Index&gt;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%">&nbsp;</TD>
    <TD STYLE="width: 85%"><FONT STYLE="font-size: 10pt">(1) With respect to each Underlier, the Closing Value of that Underlier on the Initial Valuation Date</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(2) With respect to each Underlier, 75.00% of its Initial Underlier Value (rounded to two decimal places)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Contingent Coupon:</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">$35.75 per $1,000 principal amount Note (based on a rate of 7.15%
per annum or 3.575% semiannually, rounded to four decimal places, if applicable)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If the Closing Value of <B><I><U>each</U></I></B> Underlier on
an Observation Date is <I>greater than </I>or <I>equal to</I> its Coupon Barrier Value, you will receive a Contingent Coupon on the related
Contingent Coupon Payment Date. If the Closing Value of <B><I><U>any</U></I></B> Underlier on an Observation Date is <I>less than</I>
its Coupon Barrier Value, you will not receive a Contingent Coupon on the related Contingent Coupon Payment Date.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Payment at Maturity:</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You will receive on the Maturity Date a cash payment per $1,000
principal amount Note determined as follows:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Wingdings">&sect;&#9;</FONT>If
the Final Underlier Value of the Lesser Performing Underlier is <I>greater than</I> or <I>equal to</I> its Barrier Value, you will receive
a payment of $1,000 per $1,000 principal amount Note <I>plus</I> the Contingent Coupon otherwise due</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Wingdings">&sect;&#9;</FONT>If
the Final Underlier Value of the Lesser Performing Underlier is <I>less than</I> its Barrier Value, you will receive an amount per $1,000
principal amount Note calculated as follows:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$1,000 + ($1,000 &times; Underlier Return
of the Lesser Performing Underlier)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>If the Final Underlier Value of any Underlier is less than
its Barrier Value, your Notes will be fully exposed to the decline of the Lesser Performing Underlier from its Initial Underlier Value
and you will lose a significant portion or all of your investment at maturity. Any payment on the Notes, including any repayment of principal,
is not guaranteed by any third party and is subject to (a) the creditworthiness of Barclays Bank PLC and (b) the risk of exercise of
any U.K. Bail-in Power (as described on page PS-4 of this pricing supplement) by the relevant U.K. resolution authority. See &ldquo;Selected
Risk Considerations&rdquo; and &ldquo;Consent to U.K. Bail-in Power&rdquo; in this pricing supplement and &ldquo;Risk Factors&rdquo;
in the accompanying prospectus supplement.</I></B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Consent to U.K. Bail-in Power:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Notwithstanding and to the exclusion of any other term of the Notes or any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or beneficial owner of the Notes (or the trustee on behalf of the holders of the Notes), by acquiring the Notes, each holder or beneficial owner of the Notes acknowledges, accepts, agrees to be bound by, and consents to the exercise of, any U.K. Bail-in Power by the relevant U.K. resolution authority. See &ldquo;Consent to U.K. Bail-in Power&rdquo; on page PS-4 of this pricing supplement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">(<I>Terms of the Notes continue on the next page</I>)</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 9%">&nbsp;</TD>
    <TD STYLE="padding-right: 6pt; vertical-align: bottom; width: 19%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Initial
Issue Price</B><SUP>(1)(2)</SUP></P></TD>
    <TD STYLE="padding-right: 6pt; vertical-align: bottom; width: 20%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Price
to Public</B></P></TD>
    <TD STYLE="padding-right: 6pt; vertical-align: bottom; width: 22%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Agent</B>&rsquo;<B>s
Commission</B><SUP>(3)</SUP></P></TD>
    <TD STYLE="padding-right: 6pt; vertical-align: bottom; width: 30%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Proceeds
to Barclays Bank PLC</B></P></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt"><B>Per Note</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,000</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">100%</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">3.30%</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">96.70%</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$&#9679;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$&#9679;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$&#9679;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$&#9679;</FONT></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>Because dealers who purchase the Notes for sale to certain fee-based advisory accounts may forgo some or all selling concessions,
fees or commissions, the public offering price for investors purchasing the Notes in such fee-based advisory accounts may be between $967.00
and $1,000 per $1,000 principal amount Note. Investors that hold their Notes in fee-based advisory or trust accounts may be charged fees
by the investment advisor or manager of such account based on the amount of assets held in those accounts, including the Notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>Our estimated value of the Notes on the Initial Valuation Date, based on our internal pricing models, is expected to be between $897.30
and $957.30 per $1,000 principal amount Note. The estimated value is expected to be less than the initial issue price of the Notes. See
&ldquo;Additional Information Regarding Our Estimated Value of the Notes&rdquo; on page PS-5 of this pricing supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(3)</TD><TD>Barclays Capital Inc. will receive commissions from the Issuer of up to $33.00 per $1,000 principal amount Note. Barclays Capital
Inc. will use these commissions to pay variable selling concessions or fees (including custodial or clearing fees) to other dealers. <FONT STYLE="background-color: white">Barclays
Capital Inc. may pay from these commissions a structuring fee of up to $8.00 per $1,000 principal amount Note to other broker-dealers
participating in the distribution of the Notes. In no case will the total amount of selling concessions and structuring fees exceed $33.00
per $1,000 principal amount Note.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: red"><B>Investing in the Notes involves a number of risks</B>.
<B>See </B>&ldquo;<B>Risk Factors</B>&rdquo; <B>beginning on page S-9 of the prospectus supplement and </B>&ldquo;<B>Selected Risk Considerations</B>&rdquo;
<B>beginning on page PS-11 of this pricing supplement</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The Notes will not be listed on any U</B>.<B>S</B>. <B>securities
exchange or quotation system</B>. <B>Neither the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) nor any state securities
commission has approved or disapproved of these Notes or determined that this pricing supplement is truthful or complete. Any representation
to the contrary is a criminal offense. </B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>The Notes constitute our unsecured and unsubordinated obligations.
The Notes are not deposit liabilities of Barclays Bank PLC and are not covered by the U</I>.<I>K</I>. <I>Financial Services Compensation
Scheme or insured by the U</I>.<I>S</I>. <I>Federal Deposit Insurance Corporation or any other governmental agency or deposit insurance
agency of the United States, the United Kingdom or any other jurisdiction</I>.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>(Terms of the Notes continued from previous page)</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 19%"><FONT STYLE="font-size: 10pt">Final Underlier Value: </FONT></TD>
    <TD STYLE="width: 81%"><FONT STYLE="font-size: 10pt">With respect to each Underlier, the Closing Value of that Underlier on the Final Valuation Date</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Lesser Performing Underlier:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The Underlier with the lower Underlier Return</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Underlier Return:</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With respect to each Underlier, an amount calculated as follows:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Final Underlier Value &ndash; Initial Underlier
Value</U><BR>
Initial Underlier Value</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Observation Dates:<SUP>&dagger;</SUP></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">April 30, 2026, November 2, 2026, April 30, 2027, November 1, 2027, May 1, 2028 and the Final Valuation Date</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Contingent Coupon Payment Dates:<SUP>&dagger;</SUP></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">May 5, 2026, November 5, 2026, May 5, 2027, November 4, 2027, May 4, 2028 and the Maturity Date</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Closing Value:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Closing Value has the meaning assigned to &ldquo;closing level&rdquo; set forth under &ldquo;Reference Assets&mdash;Indices&mdash;Special Calculation Provisions&rdquo; in the prospectus supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Calculation Agent:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Barclays Bank PLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Additional Terms:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Terms used in this pricing supplement, but not defined herein, shall have the meanings ascribed to them in the prospectus supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">CUSIP / ISIN:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">06746EGZ2 / US06746EGZ25</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><P STYLE="margin-top: 0; margin-bottom: 0"><SUP>*</SUP></P>
                                                    <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></TD><TD>The Underliers and the terms of the Notes are subject to adjustment by the Calculation Agent and the Maturity Date may be accelerated,
in each case under certain circumstances as set forth in the accompanying prospectus supplement. See &ldquo;Selected Risk Considerations&mdash;Risks
Relating to the Underliers&rdquo; below.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><SUP>&dagger;</SUP></TD><TD>Subject to postponement in certain circumstances, as described under &ldquo;Reference Assets&mdash;Indices&mdash;Market Disruption
Events for Securities with an Equity Index as a Reference Asset,&rdquo; &ldquo;Reference Assets&mdash;Least or Best Performing Reference
Asset&mdash;Scheduled Trading Days and Market Disruption Events for Securities Linked to the Reference Asset with the Lowest or Highest
Return in a Group of Two or More Equity Securities, Exchange-Traded Funds, Equity Indices and/or Equity Futures Indices&rdquo; and &ldquo;Terms
of the Notes&mdash;Payment Dates&rdquo; in the accompanying prospectus supplement</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_002.jpg" ALT="barclays PLC logo" STYLE="height: 45px; width: 209px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ADDITIONAL DOCUMENTS RELATED TO THE OFFERING OF THE NOTES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You should read this pricing supplement together with the prospectus
dated May 15, 2025, as supplemented by the prospectus supplement dated May 15, 2025 relating to our Global Medium-Term Notes, Series A,
of which these Notes are a part, and the underlying supplement dated May 15, 2025. This pricing supplement, together with the documents
listed below, contains the terms of the Notes and supersedes all prior or contemporaneous oral statements as well as any other written
materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures,
brochures or other educational materials of ours. You should carefully consider, among other things, the matters set forth under &ldquo;Risk
Factors&rdquo; in the prospectus supplement and &ldquo;Selected Risk Considerations&rdquo; in this pricing supplement, as the Notes involve
risks not associated with conventional debt securities. We urge you to consult your investment, legal, tax, accounting and other advisors
before you invest in the Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You may access these documents on the SEC website at www.sec.gov as
follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18.3pt"></TD><TD STYLE="width: 17.7pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Prospectus dated May 15, 2025:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><A HREF="http://www.sec.gov/Archives/edgar/data/312070/000119312525120720/d925982d424b2.htm">http://www.sec.gov/Archives/edgar/data/312070/000119312525120720/d925982d424b2.htm</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18.3pt"></TD><TD STYLE="width: 17.7pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Prospectus Supplement dated May 15, 2025:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><A HREF="http://www.sec.gov/Archives/edgar/data/312070/000095010325006051/dp228678_424b2-prosupp.htm">http://www.sec.gov/Archives/edgar/data/312070/000095010325006051/dp228678_424b2-prosupp.htm</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18.3pt"></TD><TD STYLE="width: 17.7pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Underlying Supplement dated May 15, 2025:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.85pt; text-indent: 0in"><A HREF="http://www.sec.gov/Archives/edgar/data/312070/000095010325006053/dp228705_424b2-underl.htm">http://www.sec.gov/Archives/edgar/data/312070/000095010325006053/dp228705_424b2-underl.htm</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.85pt; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our SEC file number is 1<FONT STYLE="font-size: 10pt">&ndash;</FONT>10257.
As used in this pricing supplement, &ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo; refer to Barclays Bank PLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase">consent to u<FONT STYLE="font-weight: normal">.</FONT>k<FONT STYLE="font-weight: normal">.</FONT>
bail<FONT STYLE="font-weight: normal">-</FONT>in power</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase"><FONT STYLE="text-transform: none">Notwithstanding
and to the exclusion of any other term of the Notes or any other agreements, arrangements or understandings between us and any holder
or beneficial owner of the Notes (or the trustee on behalf of the holders of the Notes), by acquiring the Notes, each holder or beneficial
owner of the Notes acknowledges, accepts, agrees to be bound by, and consents to the exercise of, any U.K. Bail-in Power by the relevant
U.K. resolution authority.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase"><FONT STYLE="font-weight: normal; text-transform: none">Under
the U.K. Banking Act 2009, as amended, the relevant U.K. resolution authority may exercise a U.K. Bail-in Power in circumstances in which
the relevant U.K. resolution authority is satisfied that the resolution conditions are met. These conditions include that a U.K. bank
or investment firm is failing or is likely to fail to satisfy the Financial Services and Markets Act 2000 (the &ldquo;FSMA&rdquo;) threshold
conditions for authorization to carry on certain regulated activities (within the meaning of section 55B FSMA) or, in the case of a U.K.
banking group company that is a European Economic Area (&ldquo;EEA&rdquo;) or third country institution or investment firm, that the relevant
EEA or third country relevant authority is satisfied that the resolution conditions are met in respect of that entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase"><FONT STYLE="font-weight: normal; text-transform: none">The
U.K. Bail-in Power includes any write-down, conversion, transfer, modification and/or suspension power, which allows for (i) the reduction
or cancellation of all, or a portion, of the principal amount of, or interest on, or any other amounts payable on, the Notes; (ii) the
conversion of all, or a portion, of the principal amount of, or interest on, or any other amounts payable on, the Notes into shares or
other securities or other obligations of Barclays Bank PLC or another person (and the issue to, or conferral on, the holder or beneficial
owner of the Notes of such shares, securities or obligations); (iii) the cancellation of the Notes and/or (iv) the amendment or alteration
of the maturity of the Notes, or the amendment of the amount of interest or any other amounts due on the Notes, or the dates on which
interest or any other amounts become payable, including by suspending payment for a temporary period; which U.K. Bail-in Power may be
exercised by means of a variation of the terms of the Notes solely to give effect to the exercise by the relevant U.K. resolution authority
of such U.K. Bail-in Power. Each holder and beneficial owner of the Notes further acknowledges and agrees that the rights of the holders
or beneficial owners of the Notes are subject to, and will be varied, if necessary, solely to give effect to, the exercise of any U.K.
Bail-in Power by the relevant U.K. resolution authority. For the avoidance of doubt, this consent and acknowledgment is not a waiver of
any rights holders or beneficial owners of the Notes may have at law if and to the extent that any U.K. Bail-in Power is exercised by
the relevant U.K. resolution authority in breach of laws applicable in England.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase"><FONT STYLE="font-weight: normal; text-transform: none">For
more information, please see &ldquo;Selected Risk Considerations&mdash;Risks Relating to the Issuer&mdash;You May Lose Some or All of
Your Investment If Any U.K. Bail-in Power Is Exercised by the Relevant U.K. Resolution Authority&rdquo; in this pricing supplement as
well as &ldquo;U.K. Bail-in Power,&rdquo; &ldquo;Risk Factors&mdash;Risks Relating to the Securities Generally&mdash;Regulatory action
in the event a bank or investment firm in the Group is failing or likely to fail, including the exercise by the relevant U.K. resolution
authority of a variety of statutory resolution powers, could materially adversely affect the value of any securities&rdquo; and &ldquo;Risk
Factors&mdash;Risks Relating to the Securities Generally&mdash;Under the terms of the securities, you have agreed to be bound by the exercise
of any U.K. Bail-in Power by the relevant U.K. resolution authority&rdquo; in the accompanying prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ADDITIONAL INFORMATION REGARDING OUR ESTIMATED VALUE OF THE NOTES
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The final terms for the Notes will be determined on the date the Notes
are initially priced for sale to the public, which we refer to as the Initial Valuation Date, based on prevailing market conditions on
or prior to the Initial Valuation Date, and will be communicated to investors either orally or in a final pricing supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our internal pricing models take into account a number of variables
and are based on a number of subjective assumptions, which may or may not materialize, typically including volatility, interest rates
and our internal funding rates. Our internal funding rates (which are our internally published borrowing rates based on variables such
as market benchmarks, our appetite for borrowing, and our existing obligations coming to maturity) may vary from the levels at which our
benchmark debt securities trade in the secondary market. Our estimated value on the Initial Valuation Date is based on our internal funding
rates. Our estimated value of the Notes might be lower if such valuation were based on the levels at which our benchmark debt securities
trade in the secondary market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our estimated value of the Notes on the Initial Valuation Date is expected
to be less than the initial issue price of the Notes. The difference between the initial issue price of the Notes and our estimated value
of the Notes is expected to result from several factors, including any sales commissions expected to be paid to Barclays Capital Inc.
or another affiliate of ours, any selling concessions, discounts, commissions or fees and any structuring fees expected to be allowed
or paid to non-affiliated intermediaries, the estimated profit that we or any of our affiliates expect to earn in connection with structuring
the Notes, the estimated cost that we may incur in hedging our obligations under the Notes, and estimated development and other costs
that we may incur in connection with the Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our estimated value on the Initial Valuation Date is not a prediction
of the price at which the Notes may trade in the secondary market, nor will it be the price at which Barclays Capital Inc. may buy or
sell the Notes in the secondary market. Subject to normal market and funding conditions, Barclays Capital Inc. or another affiliate of
ours intends to offer to purchase the Notes in the secondary market but it is not obligated to do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Assuming that all relevant factors remain constant after the Initial
Valuation Date, the price at which Barclays Capital Inc. may initially buy or sell the Notes in the secondary market, if any, and the
value that we may initially use for customer account statements, if we provide any customer account statements at all, may exceed our
estimated value on the Initial Valuation Date for a temporary period expected to be approximately six months after the Issue Date because,
in our discretion, we may elect to effectively reimburse to investors a portion of the estimated cost of hedging our obligations under
the Notes and other costs in connection with the Notes that we will no longer expect to incur over the term of the Notes. We made such
discretionary election and determined this temporary reimbursement period on the basis of a number of factors, which may include the tenor
of the Notes and/or any agreement we may have with the distributors of the Notes. The amount of our estimated costs that we effectively
reimburse to investors in this way may not be allocated ratably throughout the reimbursement period, and we may discontinue such reimbursement
at any time or revise the duration of the reimbursement period after the initial Issue Date of the Notes based on changes in market conditions
and other factors that cannot be predicted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We urge you to read the </B>&ldquo;<B>Selected Risk Considerations</B>&rdquo;
<B>beginning on page PS-11 of this pricing supplement</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>You may revoke your offer to purchase the Notes at any time prior
to the Initial Valuation Date</B>. <B>We reserve the right to change the terms of</B>, <B>or reject any offer to purchase</B>, <B>the
Notes prior to the Initial Valuation Date</B>. <B>In the event of any changes to the terms of the Notes</B>, <B>we will notify you and
you will be asked to accept such changes in connection with your purchase</B>. <B>You may also choose to reject such changes in which
case we may reject your offer to purchase</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>Selected Purchase Considerations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">The Notes are not appropriate for
all investors. The Notes may be an appropriate investment for you if all of the following statements are true:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You do not seek an investment that produces fixed periodic interest or coupon payments or other non-contingent sources of current
income, and you can tolerate receiving few or no Contingent Coupons over the term of the Notes in the event the Closing Value of at least
one Underlier falls below its Coupon Barrier Value on one or more of the specified Observation Dates.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You understand and accept that you will not participate in any appreciation of any Underlier, which may be significant, and that your
potential return on the Notes is limited to the Contingent Coupons, if any, paid on the Notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You can tolerate a loss of a significant portion or all of your principal amount, and you are willing and able to make an investment
that may have the full downside market risk of an investment in the Lesser Performing Underlier.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You do not anticipate that the Closing Value of <I>any</I> Underlier will fall below its Coupon Barrier Value on any Observation Date
or below its Barrier Value on the Final Valuation Date.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You are willing and able to accept the individual market risk of each Underlier and understand that any decline in the value of one
Underlier will not be offset or mitigated by a lesser decline or any potential increase in the value of the other Underlier.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You understand and accept the risks that (a) you will not receive a Contingent Coupon if the Closing Value of <I>any</I> Underlier
is less than its Coupon Barrier Value on an Observation Date and (b) you will lose a significant portion or all of your principal at maturity
if the Final Underlier Value of <I>any</I> Underlier is less than its Barrier Value.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You understand and accept the risk that the payment at maturity, if any, will be based <I>solely</I> on the Underlier Return of the
Lesser Performing Underlier.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You understand and are willing and able to accept the risks associated with an investment linked to the performance of the Underliers.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You understand and accept that you will not be entitled to receive dividends or distributions that may be paid to holders of the securities
composing the Underliers, nor will you have any voting rights with respect to the securities composing the Underliers.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You can tolerate fluctuations in the price of the Notes that may be similar to or exceed the downside fluctuations in the value of
the Underliers.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18.45pt"></TD><TD STYLE="width: 17.55pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You do not seek an investment for which there will be an active secondary market, and you are willing and able to hold the Notes to
maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18.45pt"></TD><TD STYLE="width: 17.55pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You are willing and able to assume our credit risk for all payments on the Notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You are willing and able to consent to the exercise of any U.K. Bail-in Power by any relevant U.K. resolution authority.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">The Notes may <U>not</U> be an appropriate
investment for you if <I>any</I> of the following statements are true:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You seek an investment that produces fixed periodic interest or coupon payments or other non-contingent sources of current income,
and/or you cannot tolerate receiving few or no Contingent Coupons over the term of the Notes in the event the Closing Value of at least
one Underlier falls below its Coupon Barrier Value on one or more of the specified Observation Dates.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You seek an investment that participates in the full appreciation of any or all of the Underliers rather than an investment with a
return that is limited to the Contingent Coupons, if any, paid on the Notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You seek an investment that provides for the full repayment of principal at maturity, and/or you are unwilling or unable to accept
the risk that you may lose a significant portion or all of the principal amount of your Notes in the event that the Final Underlier Value
of the Lesser Performing Underlier falls below its Barrier Value.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You anticipate that the Closing Value of <I>at least one</I> Underlier will decline during the term of the Notes such that the Closing
Value of <I>at least one</I> Underlier will fall below its Coupon Barrier Value on one or more Observation Dates and/or the Final Underlier
Value of <I>at least one</I> Underlier will fall below its Barrier Value.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You are unwilling or unable to accept the individual market risk of each Underlier and/or do not understand that any decline in the
value of one Underlier will not be offset or mitigated by a lesser decline or any potential increase in the value of the other Underlier.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You do not understand and/or are unwilling or unable to accept the risks associated with an investment linked to the performance of
the Underliers.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You are unwilling or unable to accept the risk that the negative performance of <I>any</I> Underlier may cause you to not receive
Contingent Coupons and/or to lose a significant portion or all of your principal at maturity, regardless of the performance of the other
Underlier.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18.45pt"></TD><TD STYLE="width: 17.55pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You seek an investment that entitles you to dividends or distributions on, or voting rights related to, the securities composing the
Underliers.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18.45pt"></TD><TD STYLE="width: 17.55pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You cannot tolerate fluctuations in the price of the Notes that may be similar to or exceed the downside fluctuations in the value
of the Underliers.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18.45pt"></TD><TD STYLE="width: 17.55pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You seek an investment for which there will be an active secondary market, and/or you are unwilling or unable to hold the Notes to
maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18.45pt"></TD><TD STYLE="width: 17.55pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You prefer the lower risk, and therefore accept the potentially lower returns, of fixed income investments with comparable maturities
and credit ratings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You are unwilling or unable to assume our credit risk for all payments on the Notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>You are unwilling or unable to consent to the exercise of any U.K. Bail-in Power by any relevant U.K. resolution authority.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>You must rely on your own evaluation of the merits of an investment
in the Notes</I><FONT STYLE="font-weight: normal">. You should reach a decision whether to invest in the Notes after carefully considering,
with your advisors, the appropriateness of the Notes in light of your investment objectives and the specific information set out in this
pricing supplement, the prospectus, the prospectus supplement and the underlying supplement. Neither the Issuer nor Barclays Capital Inc.
makes any recommendation as to the appropriateness of the Notes for investment.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">HYPOTHETICAL EXAMPLES
OF </FONT>AMOUNTS PAYABLE ON A SINGLE CONTINGENT COUPON PAYMENT DATE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following examples demonstrate the circumstances under which you
may receive a Contingent Coupon on a hypothetical Contingent Coupon Payment Date. The examples set forth below are purely hypothetical
and are provided for illustrative purposes only. The numbers appearing in the following tables and examples have been rounded for ease
of analysis. The hypothetical examples below do not take into account any tax consequences from investing in the Notes and make the following
key assumptions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><I>Hypothetical</I> Initial Underlier Value of each Underlier: 100.00*</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><I>Hypothetical</I> Coupon Barrier Value for each Underlier: 75.00 (75.00% of the hypothetical Initial Underlier Value set forth above)*</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in">*</TD><TD>The <B><I>hypothetical</I></B> Initial Underlier Value of 100.00 and the <B><I>hypothetical</I></B> Coupon Barrier Value of 75.00
for each Underlier have been chosen for illustrative purposes only and may not represent likely actual Initial Underlier Values or Coupon
Barrier Values for the Underliers. The actual Initial Underlier Value for each Underlier will be equal to its Closing Value on the Initial
Valuation Date and the actual Coupon Barrier Value for each Underlier will be equal to 75.00% of its Initial Underlier Value.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For information regarding recent values of the Underliers, please see
&ldquo;Information Regarding the Underliers&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Example 1: The Closing Value of each Underlier is greater than its
Coupon Barrier Value on the relevant Observation Date.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 45%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 1in">
  <TR STYLE="background-color: #D9D9D9">
    <TD STYLE="width: 52%; border: Black 1pt solid; text-align: center"><B>Underlier</B></TD>
    <TD STYLE="width: 48%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><B>Closing Value on Relevant Observation Date</B></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">RTY Index</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">105.000</TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">SPX Index</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">85.00</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Because the Closing Value of each Underlier is greater than its Coupon
Barrier Value, you will receive a Contingent Coupon of $35.75 per $1,000 principal amount Note (3.575% of the principal amount) on the
related Contingent Coupon Payment Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Example 2: The Closing Value of one Underlier is less than its Coupon
Barrier Value on the relevant Observation Date, and the Closing Value of the other Underlier is greater than its Coupon Barrier Value
on the relevant Observation Date.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 45%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 1in">
  <TR STYLE="background-color: #D9D9D9">
    <TD STYLE="width: 52%; border: Black 1pt solid; text-align: center"><B>Underlier</B></TD>
    <TD STYLE="width: 48%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><B>Closing Value on Relevant Observation Date</B></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">RTY Index</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">140.000</TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">SPX Index</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">40.00</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Because the Closing Value of at least one Underlier is less than its
Coupon Barrier Value, you will not receive a Contingent Coupon on the related Contingent Coupon Payment Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Example 3: The Closing Value of each Underlier is less than its
Coupon Barrier Value on the relevant Observation Date.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 45%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 1in">
  <TR STYLE="background-color: #D9D9D9">
    <TD STYLE="width: 52%; border: Black 1pt solid; text-align: center"><B>Underlier</B></TD>
    <TD STYLE="width: 48%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><B>Closing Value on Relevant Observation Date</B></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">RTY Index</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">45.000</TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">SPX Index</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">55.00</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Because the Closing Value of at least one Underlier is less than its
Coupon Barrier Value, you will not receive a Contingent Coupon on the related Contingent Coupon Payment Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Examples 2 and 3 demonstrate that you may not receive a Contingent
Coupon on a Contingent Coupon Payment Date</I>. <I>If the Closing Value of at least one Underlier is below its Coupon Barrier Value on
each Observation Date</I>, <I>you will not receive any Contingent Coupons during the term of the Notes</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>Hypothetical EXAMPLES OF
AMOUNTS PAYABLE at Maturity </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">The following table illustrates the
hypothetical payment at maturity under various circumstances. The examples set forth below are purely hypothetical and are provided for
illustrative purposes only. The numbers appearing in the following table and examples have been rounded for ease of analysis. The hypothetical
examples below do not take into account any tax consequences from investing in the Notes and make the following key assumptions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><I>Hypothetical</I> Initial Underlier Value of each Underlier: 100.00*</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><I>Hypothetical</I> Coupon Barrier Value for each Underlier: 75.00 (75.00% of the hypothetical Initial Underlier Value set forth above)*</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><I>Hypothetical</I> Barrier Value for each Underlier: 75.00 (75.00% of the hypothetical Initial Underlier Value set forth above)*</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-weight: normal">*</FONT></TD><TD><FONT STYLE="font-weight: normal">The </FONT><I>hypothetical</I> <FONT STYLE="font-weight: normal">Initial Underlier Value of 100.00,
the </FONT><I>hypothetical</I> <FONT STYLE="font-weight: normal">Coupon Barrier Value of 75.00 and the</FONT> <I>hypothetical</I> <FONT STYLE="font-weight: normal">Barrier
Value of 75.00 for each Underlier have been chosen for illustrative purposes only and may not represent likely actual Initial Underlier
Values, Coupon Barrier Values or Barrier Values for the Underliers. The actual Initial Underlier Value for each Underlier will be equal
to its Closing Value on the Initial Valuation Date, and the actual Coupon Barrier Value and Barrier Value for each Underlier will each
be equal to 75.00% of its Initial Underlier Value.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For information regarding recent values of the Underliers, please see
&ldquo;Information Regarding the Underliers&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 85%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #CCCCCC">
    <TD STYLE="width: 34%; border: Black 1pt solid; text-align: center"><B>Final Underlier Value of <BR>
the Lesser Performing Underlier</B></TD>
    <TD STYLE="width: 33%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><B>Underlier Return of <BR>
the Lesser Performing Underlier</B></TD>
    <TD STYLE="width: 33%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><B>Payment at Maturity**</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">150.00</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">50.00%</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">$1,000.00</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">140.00</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">40.00%</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">$1,000.00</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">130.00</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">30.00%</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">$1,000.00</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">120.00</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">20.00%</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">$1,000.00</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">110.00</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">10.00%</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">$1,000.00</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">100.00</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">0.00%</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">$1,000.00</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCCCCC">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">90.00</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">-10.00%</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">$1,000.00</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCCCCC">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">80.00</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">-20.00%</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">$1,000.00</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCCCCC">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">75.00</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">-25.00%</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">$1,000.00</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">74.99</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">-25.01%</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">$749.90</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">70.00</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">-30.00%</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">$700.00</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">60.00</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">-40.00%</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">$600.00</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">50.00</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">-50.00%</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">$500.00</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">40.00</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">-60.00%</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">$400.00</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">30.00</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">-70.00%</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">$300.00</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">20.00</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">-80.00%</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">$200.00</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">10.00</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">-90.00%</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">$100.00</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">0.00</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">-100.00%</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center">$0.00</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">** &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per $1,000 principal amount
Note, excluding the final Contingent Coupon that may be payable on the Maturity Date</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following examples illustrate how the payments at maturity set
forth in the table above are calculated:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Example 1</B>: <B>The Final Underlier Value of the RTY Index is
150.000 and the Final Underlier Value of the SPX Index is 130.00</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Because the SPX Index has the lower Underlier Return, the SPX Index
is the Lesser Performing Underlier. Because the Final Underlier Value of the Lesser Performing Underlier is greater than or equal to its
Barrier Value, you will receive a payment at maturity of $1,000 per $1,000 principal amount Note that you hold (<I>plus</I> the Contingent
Coupon otherwise due).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Example 1 demonstrates that you will not participate in any appreciation
in the value of any Underlier. Even though each Underlier appreciated significantly, the payment at maturity is limited to $1,000 per
$1,000 principal amount Note that you hold (<I>plus</I> the Contingent Coupon otherwise due).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Example 2: The Final Underlier Value of the RTY Index is 80.000
and the Final Underlier Value of the SPX Index is 140.00.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Because the RTY Index has the lower Underlier Return, the RTY Index
is the Lesser Performing Underlier. Because the Final Underlier Value of the Lesser Performing Underlier is greater than or equal to its
Barrier Value, you will receive a payment at maturity of $1,000 per $1,000 principal amount Note that you hold (<I>plus</I> the Contingent
Coupon otherwise due).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Example 3: The Final Underlier Value of the RTY Index is 80.000
and the Final Underlier Value of the SPX Index is 50.00.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Because the SPX Index has the lower Underlier Return, the SPX Index
is the Lesser Performing Underlier. Because the Final Underlier Value of the Lesser Performing Underlier is less than its Barrier Value,
you will receive a payment at maturity of $500.00 per $1,000 principal amount Note that you hold, calculated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$1,000 + ($1,000 &times; Underlier Return of the
Lesser Performing Underlier)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$1,000 + ($1,000 &times; -50.00%) = $500.00</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, because the Final Underlier Value of at least one Underlier
is less than its Coupon Barrier Value, you will not receive a Contingent Coupon on the Maturity Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Example 3 demonstrates that, if the Final Underlier Value of the Lesser
Performing Underlier is less than its Barrier Value, your investment in the Notes will be fully exposed to the decline of the Lesser Performing
Underlier from its Initial Underlier Value. You will not benefit in any way from the Underlier Return of the other Underlier being higher
than the Underlier Return of the Lesser Performing Underlier.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>You may lose up to 100.00% of the principal amount of your Notes</I></B><I>.
<B>Any payment on the Notes, including the repayment of principal, is subject to the credit risk of Barclays Bank PLC.</B></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Selected
Risk Considerations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">An investment in the Notes involves significant risks. Investing in
the Notes is not equivalent to investing directly in the Underliers or their components. Some of the risks that apply to an investment
in the Notes are summarized below, but we urge you to read the more detailed explanation of risks relating to the Notes generally in the
&ldquo;Risk Factors&rdquo; section of the prospectus supplement. You should not purchase the Notes unless you understand and can bear
the risks of investing in the Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Relating to the Notes Generally</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 17.85pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>Your Investment in the Notes May Result in a Significant Loss</B>&mdash;The Notes differ from ordinary debt securities in that
the Issuer will not necessarily repay the full principal amount of the Notes at maturity. If the Final Underlier Value of the Lesser Performing
Underlier is less than its Barrier Value, your Notes will be fully exposed to the decline of the Lesser Performing Underlier from its
Initial Underlier Value. <B><I>You may lose up to 100.00% of the principal amount of your Notes</I></B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>You May Not Receive Any Contingent Coupon Payments on the Notes</B>&mdash;The Issuer will not necessarily make periodic coupon
payments on the Notes. You will receive a Contingent Coupon on a Contingent Coupon Payment Date <I>only if</I> the Closing Value of each
Underlier on the related Observation Date is greater than or equal to its Coupon Barrier Value. If the Closing Value of any Underlier
on an Observation Date is less than its Coupon Barrier Value, you will not receive a Contingent Coupon on the related Contingent Coupon
Payment Date. If the Closing Value of at least one Underlier is less than its Coupon Barrier Value on each Observation Date, you will
not receive any Contingent Coupons during the term of the Notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>Your Potential Return on the Notes Is Limited to the Contingent Coupons, If Any, and You Will Not Participate in Any Appreciation
of Any Underlier</B>&mdash;The potential positive return on the Notes is limited to the Contingent Coupons, if any, that may be payable
during the term of the Notes. You will not participate in any appreciation in the value of any Underlier, which may be significant, even
though you will be fully exposed to the depreciation in the value of the Lesser Performing Underlier from its Initial Underlier Value
if the Final Underlier Value of the Lesser Performing Underlier is less than its Barrier Value.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>Because the Notes Are Linked to the Lesser Performing Underlier, You Are Exposed to Greater Risks of No Contingent Coupons and
Sustaining a Significant Loss of Principal at Maturity Than If the Notes Were Linked to a Single Underlier</B>&mdash;The risk that you
will not receive any Contingent Coupons and lose a significant portion or all of your principal amount in the Notes at maturity is greater
if you invest in the Notes as opposed to substantially similar securities that are linked to the performance of a single Underlier. With
multiple Underliers, it is more likely that the Closing Value of at least one Underlier will be less than its Coupon Barrier Value on
the specified Observation Dates or less than its Barrier Value on the Final Valuation Date, and therefore, it is more likely that you
will not receive any Contingent Coupons and that you will suffer a loss of a significant portion or all of your principal at maturity.
Further, the performance of the Underliers may not be correlated or may be negatively correlated. The lower the correlation between multiple
Underliers, the greater the potential for one of those Underliers to close below its Coupon Barrier Value or Barrier Value on an Observation
Date or the Final Valuation Date, respectively.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">It is impossible to predict what the correlation
among the Underliers will be over the term of the Notes. The Underliers represent different equity markets. These different equity markets
may not perform similarly over the term of the Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">Although the correlation of the Underliers&rsquo;
performance may change over the term of the Notes, the Contingent Coupon rate is determined, in part, based on the correlation of the
Underliers&rsquo; performance calculated using our internal models at the time when the terms of the Notes are finalized. A higher Contingent
Coupon is generally associated with lower correlation of the Underliers, which reflects a greater potential for missed Contingent Coupons
and for a loss of principal at maturity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>You Are Exposed to the Market Risk of Each Underlier</B>&mdash;Your return on the Notes is not linked to a basket consisting of
the Underliers. Rather, it will be contingent upon the independent performance of each Underlier. Unlike an instrument with a return linked
to a basket of underlying assets in which risk is mitigated and diversified among all the components of the basket, you will be exposed
to the risks related to each Underlier. Poor performance by any Underlier over the term of the Notes may negatively affect your return
and will not be offset or mitigated by any increases or lesser declines in the value of the other Underlier. To receive a Contingent Coupon,
the Closing Value of each Underlier must be greater than or equal to its Coupon Barrier Value on the applicable Observation Date. In addition,
if the Final Underlier Value of any Underlier is less than its Barrier Value, you will be fully exposed to the decline of the Lesser Performing
Underlier from its Initial Underlier Value. Accordingly, your investment is subject to the market risk of each Underlier.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>Any Payment on the Notes Will Be Determined Based on the Closing Values of the Underliers on the Dates Specified</B>&mdash;Any
payment on the Notes will be determined based on the Closing Values of the Underliers on the dates specified. You will not benefit from
any more favorable values of the Underliers determined at any other time.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>Contingent Repayment of the Principal Amount Applies Only at Maturity</B>&mdash;You should be willing to hold your Notes to maturity.
If you sell your Notes prior to such time in the secondary market, if any, you may have to sell your Notes at a price that is less than
the principal amount even if at that time the value of each Underlier has increased from its Initial Underlier Value. See &ldquo;&mdash;Risks
Relating to the Estimated Value of the Notes and the Secondary Market&mdash;Many Economic and Market Factors Will Impact the Value of
the Notes&rdquo; below.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>The Notes Are Subject to Volatility Risk</B>&mdash;Volatility is a measure of the degree of variation in the price of an asset
(or level of an index) over a period of time. The Contingent Coupon is determined based on a <FONT STYLE="background-color: white">number</FONT>
of factors, including the expected volatility of the Underliers. The Contingent Coupon will be paid at a per annum rate that is higher
than the fixed rate that we would pay on a conventional debt security of the same tenor and is higher than it otherwise would be if the
level of expected</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">volatility of the Underliers taken into
account in determining the terms of the Notes were lower. As volatility of an Underlier increases, there will typically be a greater likelihood
that (a) the Closing Value of that Underlier on one or more Observation Dates will be less than its Coupon Barrier Value and (b) the Final
Underlier Value of that Underlier will be less than its Barrier Value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">Accordingly, you should understand that
a higher Contingent Coupon reflects, among other things, an indication of a greater likelihood that you will (a) not receive Contingent
Coupons with respect to one or more Observation Dates and/or (b) incur a loss of principal at maturity than would have been the case had
the Contingent Coupon been lower. In addition, actual volatility over the term of the Notes may be significantly higher than expected
volatility at the time the terms of the Notes were determined. If actual volatility is higher than expected, you will face an even greater
risk that you will not receive Contingent Coupons and/or that you will lose a significant portion or all of your principal at maturity
for the reasons described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>Owning the Notes Is Not the Same as Owning the Securities Composing the Underliers</B>&mdash;The return on the Notes may not reflect
the return you would realize if you actually owned the securities composing the Underliers. As a holder of the Notes, you will not have
voting rights or rights to receive dividends or other distributions or other rights that holders of the securities composing the Underliers
would have.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>Tax Treatment</B>&mdash;Significant aspects of the tax treatment of the Notes are uncertain. You should consult your tax advisor
about your tax situation. See &ldquo;Tax Considerations&rdquo; below.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Relating to the Issuer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>Credit of Issuer</B>&mdash;The Notes are unsecured and unsubordinated debt obligations of the Issuer, Barclays Bank PLC, and are
not, either directly or indirectly, an obligation of any third party. Any payment to be made on the Notes, including any repayment of
principal, is subject to the ability of Barclays Bank PLC to satisfy its obligations as they come due and is not guaranteed by any third
party. As a result, the actual and perceived creditworthiness of Barclays Bank PLC may affect the market value of the Notes, and in the
event Barclays Bank PLC were to default on its obligations, you may not receive any amounts owed to you under the terms of the Notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>You May Lose Some or All of Your Investment If Any U</B>.<B>K</B>. <B>Bail-in Power Is Exercised by the Relevant U</B>.<B>K</B>.
<B>Resolution Authority</B>&mdash;Notwithstanding and to the exclusion of any other term of the Notes or any other agreements, arrangements
or understandings between Barclays Bank PLC and any holder or beneficial owner of the Notes (or the trustee on behalf of the holders of
the Notes), by acquiring the Notes, each holder or beneficial owner of the Notes acknowledges, accepts, agrees to be bound by, and consents
to the exercise of, any U.K. Bail-in Power by the relevant U.K. resolution authority as set forth under &ldquo;Consent to U.K. Bail-in
Power&rdquo; in this pricing supplement. Accordingly, any U.K. Bail-in Power may be exercised in such a manner as to result in you and
other holders and beneficial owners of the Notes losing all or a part of the value of your investment in the Notes or receiving a different
security from the Notes, which may be worth significantly less than the Notes and which may have significantly fewer protections than
those typically afforded to debt securities. Moreover, the relevant U.K. resolution authority may exercise the U.K. Bail-in Power without
providing any advance notice to, or requiring the consent of, the holders and beneficial owners of the Notes. The exercise of any U.K.
Bail-in Power by the relevant U.K. resolution authority with respect to the Notes will not be a default or an Event of Default (as each
term is defined in the senior debt securities indenture) and the trustee will not be liable for any action that the trustee takes, or
abstains from taking, in either case, in accordance with the exercise of the U.K. Bail-in Power by the relevant U.K. resolution authority
with respect to the Notes. See &ldquo;Consent to U.K. Bail-in Power&rdquo; in this pricing supplement as well as &ldquo;U.K. Bail-in Power,&rdquo;
&ldquo;Risk Factors&mdash;Risks Relating to the Securities Generally&mdash;Regulatory action in the event a bank or investment firm in
the Group is failing or likely to fail, including the exercise by the relevant U.K. resolution authority of a variety of statutory resolution
powers, could materially adversely affect the value of any securities&rdquo; and &ldquo;Risk Factors&mdash;Risks Relating to the Securities
Generally&mdash;Under the terms of the securities, you have agreed to be bound by the exercise of any U.K. Bail-in Power by the relevant
U.K. resolution authority&rdquo; in the accompanying prospectus supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Relating to the Underliers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>Each Underlier Reflects the Price Return of the Securities Composing That Underlier, Not the Total Return</B>&mdash;The return
on the Notes is based on the performance of the Underliers, which reflects changes in the market prices of the securities composing each
Underlier. Each Underlier is not a &ldquo;total return&rdquo; index that, in addition to <FONT STYLE="background-color: white">reflecting</FONT>
those price returns, would also reflect dividends paid on the securities composing that Underlier. Accordingly, the return on the Notes
will not include such a total return feature.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>Adjustments to the Underliers Could Adversely Affect the Value of the Notes</B>&mdash;The sponsor of an Underlier may add, delete,
substitute or adjust the securities composing that Underlier or make other methodological changes to that Underlier that could affect
its performance. The Calculation Agent will calculate the value to be used as the Closing Value of an Underlier in the event of certain
material changes in or modifications to that Underlier. In addition, the sponsor of an Underlier may also discontinue or suspend calculation
or publication of that Underlier at any time. Under these circumstances, the Calculation Agent may select a successor index that the Calculation
Agent determines to be comparable to the discontinued Underlier or, if no successor index is available, the Calculation Agent will determine
the value to be used as the Closing Value of that Underlier. Any of these actions could adversely affect the value of the relevant Underlier
and, consequently, the value of the Notes. See &ldquo;Reference Assets&mdash;Indices&mdash;Adjustments Relating to Securities with an
Index as a Reference Asset&rdquo; in the accompanying prospectus supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>The Notes Are Subject to Small-Capitalization Companies Risk with Respect to the RTY Index</B>&mdash;The RTY Index tracks companies
that are considered small-capitalization companies. These companies often have greater stock price volatility, lower trading volume and
less liquidity than large-capitalization companies, and therefore Notes linked to the RTY Index may be more volatile than an investment
linked to an index with component stocks issued by large-capitalization companies. Stock prices of small-capitalization companies are
also more vulnerable than those of large-capitalization companies to adverse business and economic developments. In addition, small-capitalization
companies are typically less stable financially than large-capitalization companies and may depend on a small number of key personnel,
making them more vulnerable to loss of personnel. Small-capitalization companies are often subject to less analyst coverage and may be
in early, and less predictable, periods of their corporate existences. Such companies tend to have smaller revenues, less diverse product
lines, smaller shares of their product or service markets, fewer financial resources and less competitive strengths than large-capitalization
companies and are more susceptible to adverse developments related to their products.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>We May Accelerate the Notes If a Change-in-Law Event Occurs</B>&mdash;Upon the occurrence of legal or regulatory changes that may,
among other things, prohibit or otherwise materially restrict persons from holding the Notes or an Underlier or its components, or engaging
in transactions in them, the Calculation Agent may determine that a change-in-law event has occurred and accelerate the Maturity Date
for a payment determined by the Calculation Agent in its sole discretion. Any amount payable upon acceleration could be significantly
less than any amount that would be due on the Notes if they were not accelerated. However, if the Calculation Agent elects not to accelerate
the Notes, the value of, and any amount payable on, the Notes could be adversely affected, perhaps significantly, by the occurrence of
those legal or regulatory changes. See &ldquo;Terms of the Notes&mdash;Change-in-Law Events&rdquo; in the accompanying prospectus supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>Historical Performance of the Underliers Should Not Be Taken as Any Indication of the Future Performance of the Underliers Over
the Term of the Notes</B>&mdash;The value of each Underlier has fluctuated in the past and may, in the future, experience significant
fluctuations. The historical performance of an Underlier is not an indication of the future performance of that Underlier over the term
of the Notes. The historical correlation between the Underliers is not an indication of the future correlation between them over the term
of the Notes. Therefore, the performance of the Underliers individually or in comparison to each other over the term of the Notes may
bear no relation or resemblance to the historical performance of any Underlier.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Relating to Conflicts of Interest</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>We and Our Affiliates May Engage in Various Activities or Make Determinations That Could Materially Affect the Notes in Various
Ways and Create Conflicts of Interest</B>&mdash;We and our affiliates play a variety of roles in connection with the issuance of the Notes,
as described below. In performing these roles, our and our affiliates&rsquo; economic interests are potentially adverse to your interests
as an investor in the Notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">In connection with our normal business
activities and in connection with hedging our obligations under the Notes, we and our affiliates make markets in and trade various financial
instruments or products for our accounts and for the account of our clients and otherwise provide investment banking and other financial
services with respect to these financial instruments and products. These financial instruments and products may include securities, derivative
instruments or assets that may relate to the Underliers or their components. In any such market making, trading and hedging activity,
and other financial services, we or our affiliates may take positions or take actions that are inconsistent with, or adverse to, the investment
objectives of the holders of the Notes. We and our affiliates have no obligation to take the needs of any buyer, seller or holder of the
Notes into account in conducting these activities. Such market making, trading and hedging activity, investment banking and other financial
services may negatively impact the value of the Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">In addition, the role played by Barclays
Capital Inc., as the agent for the Notes, could present significant conflicts of interest with the role of Barclays Bank PLC, as issuer
of the Notes. For example, Barclays Capital Inc. or its representatives may derive compensation or financial benefit from the distribution
of the Notes and such compensation or financial benefit may serve as an incentive to sell the Notes instead of other investments. Furthermore,
we and our affiliates establish the offering price of the Notes for initial sale to the public, and the offering price is not based upon
any independent verification or valuation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">In addition to the activities described
above, we will also act as the Calculation Agent for the Notes.&nbsp;As Calculation Agent, we will determine any values of the Underliers
and make any other determinations necessary to calculate any payments on the Notes. In making these determinations, we may be required
to make discretionary judgments, including those described in the accompanying prospectus supplement and under &ldquo;&mdash;Risks Relating
to the Underliers&rdquo; above. In making these discretionary judgments, our economic interests are potentially adverse to your interests
as an investor in the Notes, and any of these determinations may adversely affect any payments on the Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Relating to the Estimated Value of the Notes and the Secondary
Market</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>Lack of Liquidity</B>&mdash;The Notes will not be listed on any securities exchange. Barclays Capital Inc. and other affiliates
of Barclays Bank PLC intend to make a secondary market for the Notes but are not required to do so, and may discontinue any such secondary
market making at any time, without notice. Barclays Capital Inc. may at any time hold unsold inventory, which may inhibit the development
of a secondary market for the Notes. Even if there is a secondary market, it may not provide enough liquidity to allow you to trade or
sell the Notes easily. Because other dealers are not likely to make a secondary market for the Notes, the price at which you may be able
to trade your Notes is likely to depend on the price, if any, at which Barclays Capital Inc. and other affiliates of Barclays Bank PLC
are willing to buy the Notes. The Notes are not designed to be short-term trading instruments. Accordingly, you should be able and willing
to hold your Notes to maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>Many Economic and Market Factors Will Impact the Value of the Notes</B>&mdash;The value of the Notes will be affected by a number
of economic and market factors that interact in complex and unpredictable ways and that may either offset or magnify each other, including:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>the values and expected volatility of the Underliers;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>correlation (or lack of correlation) of the Underliers;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>the time to maturity of the Notes;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>dividend rates on the components of each Underlier;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>interest and yield rates in the market generally;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>a variety of economic, financial, political, regulatory or judicial events;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>supply and demand for the Notes; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>our creditworthiness, including actual or anticipated downgrades in our credit ratings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>The Estimated Value of Your Notes Is Expected to Be Lower Than the Initial Issue Price of Your Notes</B>&mdash;The estimated value
of your Notes on the Initial Valuation Date is expected to be lower, and may be significantly lower, than the initial issue price of your
Notes. The difference between the initial issue price of your Notes and the estimated value of the Notes is expected as a result of certain
factors, such as any sales commissions expected to be paid to Barclays Capital Inc. or another affiliate of ours, any selling concessions,
discounts, commissions or fees and any structuring fees expected to be allowed or paid to non-affiliated intermediaries, the estimated
profit that we or any of our affiliates expect to earn in connection with structuring the Notes, the estimated cost which we may incur
in hedging our obligations under the Notes, and estimated development and other costs which we may incur in connection with the Notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>The Estimated Value of Your Notes Might Be Lower If Such Estimated Value Were Based on the Levels at Which Our Debt Securities
Trade in the Secondary Market</B>&mdash;The estimated value of your Notes on the Initial Valuation Date is based on a number of variables,
including our internal funding rates. Our internal funding rates may vary from the levels at which our benchmark debt securities trade
in the secondary market. As a result of this difference, the estimated values referenced above might be lower if such estimated values
were based on the levels at which our benchmark debt securities trade in the secondary market.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>The Estimated Value of the Notes Is Based on Our Internal Pricing Models</B>, <B>Which May Prove to Be Inaccurate and May Be Different
from the Pricing Models of Other Financial Institutions</B>&mdash;The estimated value of your Notes on the Initial Valuation Date is based
on our internal pricing models, which take into account a number of variables and are based on a number of subjective assumptions, which
may or may not materialize. These variables and assumptions are not evaluated or verified on an independent basis. Further, our pricing
models may be different from other financial institutions&rsquo; pricing models and the methodologies used by us to estimate the value
of the Notes may not be consistent with those of other financial institutions which may be purchasers or sellers of Notes in the secondary
market. As a result, the secondary market price of your Notes may be materially different from the estimated value of the Notes determined
by reference to our internal pricing models.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>The Estimated Value of Your Notes Is Not a Prediction of the Prices at Which You May Sell Your Notes in the Secondary Market, If
Any, and Such Secondary Market Prices, If Any, Will Likely Be Lower Than the Initial Issue Price of Your Notes and May Be Lower Than the
Estimated Value of Your Notes</B>&mdash;The estimated value of the Notes will not be a prediction of the prices at which Barclays Capital
Inc., other affiliates of ours or third parties may be willing to purchase the Notes from you in secondary market transactions (if they
are willing to purchase, which they are not obligated to do). The price at which you may be able to sell your Notes in the secondary market
at any time will be influenced by many factors that cannot be predicted, such as market conditions, and any bid and ask spread for similar
sized trades, and may be substantially less than our estimated value of the Notes. Further, as secondary market prices of your Notes take
into account the levels at which <B>o</B>ur debt securities trade in the secondary market, and do not take into account our various costs
related to the Notes such as fees, commissions, discounts, and the costs of hedging our obligations under the Notes, secondary market
prices of your Notes will likely be lower than the initial issue price of your Notes. As a result, the price at which Barclays Capital
Inc., other affiliates of ours or third parties may be willing to purchase the Notes from you in secondary market transactions, if any,
will likely be lower than the price you paid for your Notes, and any sale prior to the Maturity Date could result in a substantial loss
to you.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><B>The Temporary Price at Which We May Initially Buy the Notes in the Secondary Market and the Value We May Initially Use for Customer
Account Statements</B>, <B>If We Provide Any Customer Account Statements at All</B>, <B>May Not Be Indicative of Future Prices of Your
Notes</B>&mdash;Assuming that all relevant factors remain constant after the Initial Valuation Date, the price at which Barclays Capital
Inc. may initially buy or sell the Notes in the secondary market (if Barclays Capital Inc. makes a market in the Notes, which it is not
obligated to do) and the value that we may initially use for customer account statements, if we provide any customer account statements
at all, may exceed our estimated value of the Notes on the Initial Valuation Date, as well as the secondary market value of the Notes,
for a temporary period after the initial Issue Date of the Notes. The price at which Barclays Capital Inc. may initially buy or sell the
Notes in the secondary market and the value that we may initially use for customer account statements may not be indicative of future
prices of your Notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">Information Regarding
the UNDERLIERS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Russell 2000<SUP>&reg;</SUP> Index</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The RTY Index measures the capitalization-weighted price performance
of 2,000 U.S. small-capitalization stocks listed on eligible U.S. exchanges and is designed to track the performance of the small-capitalization
segment of the U.S. equity market. For more information about the RTY Index, see &ldquo;Indices&mdash;The Russell Indices&rdquo; in the
accompanying underlying supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Historical Performance of the RTY Index</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The graph below sets forth the historical performance of the RTY Index
based on the daily Closing Values from January 2, 2020 through October 14, 2025. We obtained the Closing Values shown in the graph below
from Bloomberg Professional<SUP>&reg;</SUP> service (&ldquo;Bloomberg&rdquo;). We have not independently verified the accuracy or completeness
of the information obtained from Bloomberg.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Historical Performance of the Russell 2000<SUP>&reg;</SUP>
Index</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><IMG SRC="image_001.gif" ALT="" STYLE="height: 347px; width: 671px"></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE
RESULTS</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>S&amp;P 500<SUP>&reg;</SUP> Index</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The SPX Index consists of stocks of 500 companies selected to provide
a performance benchmark for the U.S. equity markets. For more information about the SPX Index, see &ldquo;Indices&mdash;The S&amp;P U.S.
Indices&rdquo; in the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Historical Performance of the SPX Index</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The graph below sets forth the historical performance of the SPX Index
based on the daily Closing Values from January 2, 2020 through October 14, 2025. We obtained the Closing Values shown in the graph below
from Bloomberg. We have not independently verified the accuracy or completeness of the information obtained from Bloomberg.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Historical Performance of the S&amp;P 500<SUP>&reg;</SUP>
Index</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><IMG SRC="image_002.gif" ALT="" STYLE="height: 346px; width: 671px"></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE
RESULTS</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>Tax Considerations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You should review carefully the sections in the accompanying prospectus
supplement entitled &ldquo;Material U.S. Federal Income Tax Consequences&mdash;Tax Consequences to U.S. Holders&mdash;Notes Treated as
Prepaid Forward or Derivative Contracts with Associated Coupons&rdquo; and, if you are a non-U.S. holder, &ldquo;&mdash;Tax Consequences
to Non-U.S. Holders.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In determining our reporting responsibilities, if any, we intend to
treat (i) the Notes for U.S. federal income tax purposes as prepaid forward contracts with associated contingent coupons and (ii) any
Contingent Coupon payments as ordinary income, as described in the section entitled &ldquo;Material U.S. Federal Income Tax Consequences&mdash;Tax
Consequences to U.S. Holders&mdash;Notes Treated as Prepaid Forward or Derivative Contracts with Associated Coupons&rdquo; in the accompanying
prospectus supplement. Our special tax counsel, Davis Polk &amp; Wardwell LLP, has advised that it believes this treatment to be reasonable,
but that there are other reasonable treatments that the Internal Revenue Service (the &ldquo;IRS&rdquo;) or a court may adopt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Sale, exchange or redemption of a Note.</I> Assuming the treatment
described above is respected, upon a sale or exchange of the Notes (including redemption at maturity), you should recognize capital gain
or loss equal to the difference between the amount realized on the sale or exchange and your tax basis in the Notes, which should equal
the amount you paid to acquire the Notes (assuming Contingent Coupon payments are properly treated as ordinary income, consistent with
the position referred to above). This gain or loss should be long-term capital gain or loss if you hold the Notes for more than one year,
whether or not you are an initial purchaser of the Notes at the issue price. The deductibility of capital losses is subject to limitations.
If you sell your Notes between the time your right to a Contingent Coupon payment is fixed and the time it is paid, it is likely that
you will be treated as receiving ordinary income equal to the Contingent Coupon payment. Although uncertain, it is possible that proceeds
received from the sale or exchange of your Notes prior to an Observation Date but that can be attributed to an expected Contingent Coupon
payment could be treated as ordinary income. You should consult your tax advisor regarding this issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As noted above, there are other reasonable treatments that the IRS
or a court may adopt, in which case the timing and character of any income or loss on the Notes could be materially affected. In addition,
in 2007 the U.S. Treasury Department and the IRS released a notice requesting comments on the U.S. federal income tax treatment of &ldquo;prepaid
forward contracts&rdquo; and similar instruments. The notice focuses in particular on whether to require investors in these instruments
to accrue income over the term of their investment. It also asks for comments on a number of related topics, including the character of
income or loss with respect to these instruments and the relevance of factors such as the nature of the underlying property to which the
instruments are linked. While the notice requests comments on appropriate transition rules and effective dates, any Treasury regulations
or other guidance promulgated after consideration of these issues could materially affect the tax consequences of an investment in the
Notes, possibly with retroactive effect. You should consult your tax advisor regarding the U.S. federal income tax consequences of an
investment in the Notes, including possible alternative treatments and the issues presented by this notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Non-U.S. holders.</I> Insofar as we have responsibility as a withholding
agent, we do not currently intend to treat Contingent Coupon payments to non-U.S. holders (as defined in the accompanying prospectus supplement)
as subject to U.S. withholding tax. However, non-U.S. holders should in any event expect to be required to provide appropriate Forms W-8
or other documentation in order to establish an exemption from backup withholding, as described under the heading &ldquo;&mdash;Information
Reporting and Backup Withholding&rdquo; in the accompanying prospectus supplement. If any withholding is required, we will not be required
to pay any additional amounts with respect to amounts withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Treasury regulations under Section 871(m) generally impose a withholding
tax on certain &ldquo;dividend equivalents&rdquo; under certain &ldquo;equity linked instruments.&rdquo; A recent IRS notice excludes
from the scope of Section 871(m) instruments issued prior to January 1, 2027 that do not have a &ldquo;delta of one&rdquo; with respect
to underlying securities that could pay U.S.-source dividends for U.S. federal income tax purposes (each an &ldquo;Underlying Security&rdquo;).
Based on our determination that the Notes do not have a &ldquo;delta of one&rdquo; within the meaning of the regulations, we expect that
these regulations will not apply to the Notes with regard to non-U.S. holders. Our determination is not binding on the IRS, and the IRS
may disagree with this determination. Section 871(m) is complex and its application may depend on your particular circumstances, including
whether you enter into other transactions with respect to an Underlying Security. If necessary, further information regarding the potential
application of Section 871(m) will be provided in the pricing supplement for the Notes. You should consult your tax advisor regarding
the potential application of Section 871(m) to the Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>SUPPLEMENTAL PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We will agree to sell to Barclays Capital Inc. (the &ldquo;agent&rdquo;),
and the agent will agree to purchase from us, the principal amount of the Notes, and at the price, specified on the cover of this pricing
supplement. The agent will commit to take and pay for all of the Notes, if any are taken. The agent will pay (and be reimbursed by the
Issuer for) structuring fees to other broker-dealers participating in the distribution of the Notes, as described on the cover of this
pricing supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  @ (4# 2(  A$! Q$!_\0
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IZ;:7+AY[:&1A_$Z FK"((U"J % P .U3SKEY4:*B_:<['4445F=!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  M -$# 2(  A$! Q$!_\0
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%110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.gif
M1TE&.#=AGP); 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M( "B\0 ,Z*,V%X(3!!!@@0)$P *.BPWZ-$C#GDPO) C03G[B)! "-$!=<:I
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M &8P(__,(1& E3/2N#+;^2,.$,0( ," ]T5A'W &R8HE@D&!C< !=_9(OBY
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MGN<2358#]L<0@#<4SL!T;#$"43 \CC<",>0,.R""?S("4/ ^SN!N[Y9Y'<<
M7[<0#L  0(!P!>%X!R@0:T<0VI<0NE<0&D</4! %,3 "(]=])^%K308$/Z@0
MH+=!,]06 =!\DV=TZ[ -1M!_3("$!"%R.^  ""!]P1=[%S "8<< 6[<0LY:
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M=$&A8Q;U=K-A,8D)Z&U-5G32"07:,LD"H<-#.;@9$=*(P6:IK!!,( B>%@.
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MP@@@#DJ^A!E3YDR'0!A<O,!D&X 1#(#4\!A@!SZ:'ITY<,9@F[.B14>,8 *
M0E.9#)@\I;##P4ZJ'XU<<+ANS8X13->,6&=SA]"71B@P6-=5[MR8.^):'+&&
M+LP# RKN%2F@85=P#_X"1IP8@+,=>%TJAASY(A.@%IV-2,C  9.I'M=$77>7
M*@4'%QQDE=P1 0-Z4=&F3JAR[?^ZJ3N8!(#\VN$:>E^=T4O(!$A4F B8/(:=
M/&:,P]LX*^<(CA_TA ?F'GA@G?IVD#6 .]PFFOOXER+ 6KQPT^2Z&I4[T@,B
M]3O5'4!98Z;NP*7F*/,E4[#IHC7$ VP$KF);S %Z.ENGIYA.(I \\NP**P8)
M$_!+PJ:P.TS#\1;T,,22W*,I)0KP:XH>*)C:#$7E0.S)&2,2NB#"O1R @L 1
M_"O0(P> $,T9&T4DTB,#'4) +_(P+#(F[#9J4KD1FCDO2BOEHF<'>ERTR($A
M.[(J+F> H! Z1::*PB4*M8PL2XY.7 .WA+R<BTN' HBBRBOWO(@YKM:QD+R^
M.N2SH\+_""UT+PJBF#%11U_"L34C>?R(@36J9.POE5);E"FF - , +(B<\O(
M/Y_KZJ2/A'RTT!C64>\M":5KM2/LM*NU3B5SY?5-*(P@[J+6=@VIK(MV.&_+
MHA U,HI/$Z( BC4^^Q(F\6 5=<A7H=UQKA@.[-51 _$#<<D,P^4P7*H<L%/=
M7)V!XBKQ*%B'B6E'LHVCI()K]R-ZGMV!6(ZVO"#+?]%C KARBY)MOM9J4*^C
M'?X:X8+&NJ*@&7<?C6&EJ=9XEKN^W'UR8YJ\,UG=$;34DPDC)@X4I ;I(3#)
MA%9FMJ,+H,!OG6;ZS6P'(^ "2=:F)H J1ZF,8+>SCE"^(,XR_VG*DLV4^5P#
M@1AB8&)B"0<M"@,,])%@; D@4.Z $'*^&B0%V^9UP:D;?&J=BT&RN".[ 8B:
MZ)&LBBK+KMFN[ZF0]DTQBAI.I."WG;]<:3/@C#B  CU?JK>9:N'6, 9GF(BA
M&2!GG8ZF=="P(G75?5 NH\LY]\B(!1N%O=5++=KA@!&T%HD!IRU2U3L&7K\H
M + TRVL'!E8.^:+A5PX)5CEIVN'3K!:G(%B]F8!"X\76 $+@DM*;NG8BLV;T
M@B@VEPQ#MD>" (,TTA! 'P@22%LC\S\*P%X&FM_?GK)F$I-@9AMY"\D:B/(>
MTE# " "T2/;T I<="*(]78-@0@8T O]<>60;Y9/)  &0) LY$"3A(8U#<@*$
MZ;VD!G0*()%B *"I,(%X:1M 5];1CP=(H +0L8</%AA#RY %:$0\'UA*%:@
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M=97LS28BKE47O/;=5XH+%^;LTHZA=ZSLJ*99,@&+HS+MUS8?398,#-AGAXB
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M]&,!.XDS6F52)EP+)A_1\ D:_&03"<2I F@()4[H885TPR0!5B#T32S0N28
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MB@*4\LM$ L47R'43$(+2/ZD?V1<+Z2R@<=8+:DHJ#[Z0P429+%L$6,%<]$,
M!D8X4)B&(< %^-WJ[!Y,X!RT.$2D8$4^)"!*L,GE/=R</ G2R5[J]-W&E41#
M](,%/,#.S4,32( /2$"7(=P#3!0 A$NX:>!)H. "S!X K$,X(( %& I,^$.;
MZ%A!-/\!OA5;UMT?//C JT" H)G$@<D=EZ2@GZ&<3!"<_6G9 2   CA#@+'$
M)\F)VF' 5!0*8=2#G%$7E5#; \@;3 0AE:1& %";M\7$.H0. ,B=0:"6243
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M'Q6IF_1=$[#G3<"#FD:;E?H?&E0 BU[$ #R>#W3.9@) .&P8F[H% N3#X$E
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M&63YXL688N@![(.5;"I-)$"BVD 3M"W7ZMZ@$$N<X5Q*V02FJ-T^..'SLL0
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4-5JGM5JO-5NWM5N_-5QW2$   #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_002.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.gif
M1TE&.#=AGP): 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
M    GP): 8?____.SL[>WMY[A'O%Q<4Z.CK>YM[6SM;O]_>MM;6]O;V<G)RM
MK:7O[^^EG*5[<WN4E)2,C(1K<VM*2DJ<O=Z,K<[.WN_>YO>USN:4YA#.K1"4
MK1 9K;49YK5K8V,9*2%SG,5*I;7.<^9*YN9*K>:4<^9*YK7.K=Y:YHQ:YCI:
MK8Q:K3I:YF-:YA!:K6-:K1!*$!E".DJ,[WM[:T)*6AF$SK5:8V,9,5+6YGM:
M,=X9>UK6K7L9>QFUYGNUK7O%<X2]YKW.0HR40HS.$(R4$(Q[I=X96LX9$(R4
MI>924EI*>QF$[[6MM>92>[W%SN:MM=8(" !:6LY:$(SOWL6$G*U:>^;.0N_.
M0JV40JV40N]*&6/.$*V4$*W.$.^4$._.0LZ40LY*&4+.$,Z4$,Z]YD*$YD*]
MK4*$K4((K>8(YN:]<[6$<[6]YA I6I36>QG6.AF4.AFM>QG6$!F4$!D96N\9
M$*TI$-X9>\X9,8P(6I366AFU.AES.AFM6AFU$!ES$!D($-X0$!DQ,2%:>Z64
MYN:,O8Q[>Q#W6A#W&1#WG!!SYN:,O6M[6A!26H36>UK6.EI2,1F4.EHIYHPI
MYCHIK8PIK3I:6N^M>UK6$%J4$%HIYF,IYA IK6,IK1!:$*U:6J49$&-:$.\I
M6EH96BE:,8S66EJU.EIS.EH(YHP(YCH(K8P(K3JM6EJU$%IS$%H(YF,(YA (
MK6,(K1 9$$):$,X(6EH96@A:>X0I>Y09>^\9,:TI,=X(>Y0(,=[>YD*EYD+>
MK4*EK4(IK>8IYN;><[6E<[7>YA#WWA#.I:WW6I3W6D+W&4+W&93WG$+WG)00
M,0CW6FOW&6OWG&M2<TI:,:V,E'/>YKU[Q>;WI;WW0KWW<[WW$+VUYN_WWI3W
MWD+WWFOWI>_W0N_W<^_W$._O__^$6F/OWO>$>V.,<X3W_SKW_[W6O:W6SK76
MI<7>UN^MG*V]SK7WUN^USLZ$E)RMM:5[A(S>]]ZEK:U2.CJ$E)2EG+6]O:W>
MSM;6Q<6MK;7>SMX(_P !"!Q(L*#!@P@3*ES(L*'#AQ C2IQ(L:+%BQ@S:MS(
ML:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-FSASZMS)LZ?/GT"#"AU*
MM*C1HTB3*EW*M*G3IU"C2IU*M:K5JUBS:MW*M:O7KV##BAU+MJS9LVC3JEW+
MMJW;MW#CRIU+MZ[=NWCSZMW+MZ_?OX #"QY,N+#APX@3*U[,N+'CQY C2YY,
MN;+ERY@S:][,N;/GSS,%*!!@4#1I@0$4-!BH0 'HU[!C V"7Y,$$UP,#3+#M
M>D'M":0?>/"01+;QXY<++ "PH #! O0 ,$@2H( !  \&*)@@< (#Y.##-_^.
M($' @P<#!10@+6"";X$,;#R0(/"\^/OX"2M(0APW@.JKJ?= <0!LYT$$]=F0
MD  !-.C@@Q!&*.&$%%9HX8489JCAAAQVZ.&'((8HXH@DEFCBB2BFJ.**++;8
MX&HC-5" :]6=IAY[!4! X'02H(>=CP0M,-P'#T10#SK5')ED!$4RF20Z1C(9
M@91*'AEEDP\\N2261B)I93U2.EEEF%@^>>6468[)I9A0@EEFE5Z2:::;:'8Y
MIYQJULGFF6QNJ6>:;>(9YYJ \@FHEG3NF6B1<!J**)EV?BFHGX(ZFF>EBR(:
MZ)N;UMEHII<RZF6G?2Z*YIV<4LJII:.JBJJGH[+_JNJIDJ9JJJ*3WEHHJ*WR
M:FBDI!ZJZZNE0EHDC"$)\($[ A5@C4 R!E!@$NPX!P"3TPF4Q'(%-7 !.Q\@
MF]^XY!H5 ) B#0?/<.0(P*QO^RWGP0,*%!   MLN,,%U![E3@+CE!BPP3P(,
M #!("SPPCT +Y,-P-0X(1 Z3N)DWP&D'6?,! @-W[/%-3J![$@/^7>2O.1^G
MK+)+UCS <4H!'$R1 (+(O/+-.'OTSP!'W9CSST!S9)[-/CE1<]!()SU1 #P;
MI1ZS2D<M]8(/$-V3-4=/K?76YAWE+]1;AYUTNP8[':[8:"-];L__INUVSN:]
M3!0_Z[UMM\I,L\WOW7P+_SRTN6WW+3BY>3M=]^"(W_=W431;G?CCGA7.> %@
M0V[Y:XL3]<_9EW?^60 1D&/XWIZ7GEGF0ZGGN.FL-R8Y43ZW+OMDJ O%#^>S
MY^[8ZZD7@++NP"]6>U :KQ[\\7P%4(W7AR/OO&## Z7Z\]0#%C+;&%>O?5XM
M&Y\3@-N'CY<3RX^$@' >R(?L^?,&.!RW"O2W8//BUQ]7]!T)P""1!,UG@ ?U
M (![U$./!MRF.M(ZR.V\9[\&BF5M)F$ =P82K?],8!\%$)V0=*2M\I7&=PX,
M(5OPYY$"?"<WU@& >B*PH]HT;3X(48_<1$C#LG2M)/42ES5 N$("^6,"/:J/
M!_\,DAH'?. =UFB- /S1('\(( 'L< (#1*.  .S#":U)36I&PT0K8C&*4VR-
M$ZZHQ"XZ$8I2I&(:LUC%,C:(C&!4(QE'PX &<3&.8O1'$A4P1BS2T8Y:]*(2
MP]C&+2[QC5]<8R'=&( SXI&/A-0B(^&HR#X.THY+?*0B)<E%1"J  (*D(Q4Y
M>4A!/I*49GRB)@F)14-VD9*LG*, ZIB:3%8RDFWL9"-5J<A9CC*7I83E+UW9
M1%ZRDA[\$",P7YG(6/JQE%-DI@).N<QBHM&9EZRE-*E)S%U><Y2RI*4NA2E&
M6:;RFV+$93<=6<EP8G*;FZRF-T]IS@8E0#2I*1M)A%/_$'^1QAH3>,<$&7 @
M^@!  @@J2,(D$(@'). =$5! -1C  '3 (P(.2 "]YK$ !=!K 1%U:$7A@8Y[
M,. ![,"H1A4 4H_NPP$1G>A(2UI1!42@HQ\-J0+N\0"24A2E]<"I B   9>V
M] '^.*E-38H.FPKUJ"^-: 1^*@]T+&"E$'AJ2!,PTY^F-*,?G8='61I3BEJ4
MIDV]Z5B/NM.>HL.K01TK48T:TJ32*P),=>I:==K2J9[TJUC5JD>Y>E:OJC2L
M>Y6H62_J ']40Z\Y=>D]"OO7N-)KK@_8QU'MNM21JC6RD?6K13'J6 7,HZB@
M)2QC_WI8EHHUM!25J@,8(-6._SX6JI/U*6O!RE+41E6B294M:U]+UL2*EK%R
M7< ^4OL.[43@';M=Z0*(V]?%HM6T@G6H YQK6-Y"%::*G6E>/UM<>MU#JHO%
MJ%Q]>]2'.G>V*&WM=(UKW;SF([N_?0!% UB2;1G$/<Q)P@7JYH%YZ*99)2N(
MM6K(X+&0<",(F  \!K* [PB /TD@S3XF0)S5L# )"<U8X!I,8J_<D"3B8@"W
M&B  9.F/("].R#_H5^(:8R5N*F& $S2B+ ;:^,=)X9U0U/,[(!M9*@\F6-:.
MS&2G"#DH3VNRE)F2Y)WT>,I8/@H&GN!!V*4PRV &B@4H ()!H,/'-IE>F-><
M$W=@ /\ %,  .091#=$59<;98[.>95*!"ES@"0)I0CW07!/P[?G0,+$ !LAL
MYR8, GN(CC1++@ ""RAZ(((F-$V*)^E.G\0"()BA0 818J*<S-.H'@DW &V0
M"E3-:4M.M:PY\@0+9$QD0Z;QK'<MD09@  $5H$ ,7684HVF:U[)>M*^#[0X0
M).1ZAJL<LJ>=$"2 X-H4<$(%;#WL8\MDA]ZFMIX;\+(&"!L$11#(!132LJ/@
M6=SP!@ "0( $CH% V-INR#\&;;9PQSO+6U8T!D(M$%$CY,G2 ^&_IUUI !0!
M%^N&2)5U<N6%H[H!HFL -RJP8P!<V^ +0?A/U$,ZBT?Z AS_OS:K/1YQB;^:
M<;$V.:(I700+.('; 'BS1$3N$R++O-,8<(>_T_-RHE2GY#]GLP"$O1'0V=G+
M>4XZZV2F<Y TX!H@K\C$,9(P;@7I 2NFF$!:]H"HIR?F4C?=$ZJ>\PHX.R3N
MJ$!'>+Z1>40 '@5 %PNW(R\)U$L!$5Z OLRN0LJE?7!;Q@#&$^+V=2N^TA08
M>D(HL'(>%QTD/OO'/BAHKP+=QEKD<0"!DN"P@QS]\'T#-06:0'F$6. )JZ?T
MM0%0ZXZ0 VH5R'I%E$>2Z@C'!BY.87ORX</:^(B?!S' @E'_-D5S# ,7.#?;
MX4P."X0 !$S0^:4Y,O W4^#IEI>\_T(4 (7OO <U;1,0@0S$WP<HJ" 1($X@
M/ !2_=)?2 Q J ,\<-(!$/2\$D!0#<-_$I!5_%<D^'<> H@M]#</!WA3!^A_
M'L!3]@=2 5B "0B!)U6!##A=!(A1$4A0&[B  7A_'[A__?=_Y"& ^?"!"5@/
M(JB ]+>")IA_()B"$U@-''B!!GA2&BB#%BB ^*=_(3B!0$B#@O> "2B! "B
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M4@3S=FT@,*,*H:B8NQ,UNZD4X&=U&[5 P:*N^Q;;V*%6@ZV6!@*OBA #AZQ
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M#4[ #@P2 *;AR:-AR@PBRO+ #P$@RJC\RJ0,#__0R@*PRDDTRJ5,RJ<LR@H
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M E%@>KQ\?7P51;!N<K>\GVK$DF$>+LX0"8,.=H> W>(=#< DEWI053,O$<8
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M#0!+2L($&+* !30@> L9WELRLR2#^&,"$D#*&V\X1PEX(! $S,<#%. !.CZ
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M@ M8PPGF8.UJ#9#; ,S6M;Z=+7-HR]L&\!:VLJ6M;8-KV]VZMK6KQ:T @AL
M?ER N+Q];F^5V]O5%M>US5UM;?^Q7"<8P!\86&T%J.!<WOIVM<+-+GA[V][P
M7I>]KHWN>]^+7?[^UK;Y+:]]H=O> #CAN=4U+F_ITY5[8( ?O:V  *S!6N,Z
MP1_C$X 3YBM<B05 ,;ZQAGY_2UWKKO9$5 #-(#! !1 TH7>L]6V+GZ"/!@B
M'_(%P2#(HH_95J )*K:MC;]+8.<Z@1_N??_QB*5+VP>7N+NL#3(_G*O:_0K
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MH(VJH:6'29J'NHI9F$W:E*7:IKW:KT7;HXW9A9K9K+58A.5:J)7:?*+:?'
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M6>6,X4$6%WL_9EEFAPEV2=Q 8(J)(9E-^A.!:H$*JEH2@)96*  1>-# ! H
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M[ '  'TBX+2WAUL$.MX R3]+ 9?*5/ QK[ DT*,!@EAZ3_D%' ]7:U_'$C!
M(12(W%J+KEV;;[0<L"BT8JL>9^/XM21%9IM;"QZVP:SV@8J3,4JSP<H#A%@!
M%."LV$9\!># B :DV%OUI1JCC%?*N0H"L .D,!RWE)EI2,!XV9ZL19KAN5NK
M1,!?T<,$6)RUB$8U@&#(R<J.F88!R-E>M6"6;> %E@H"H.!I(,L$I!5JX4HU
ML&#;R?]5A)W5\4V,9Z$3%' .LE&9 "0!.U1*("QAWMV/.03"!\R639T1:4B
M93T %( ?M=2#;;B6"+I*;WG8\@$  :Q=_>S< LAA%(K0%$J0<F&AJ3 *!(C=
M#7(4;/C<;BQ6QZE5 5Q !-CALS  %%28A1U=(*"?RJS;HL":KE31M,!::P";
M:$#()BJ+!TQ NHC3D:U@HA"7$SB?JCW ;F":HRQ B$G+C''B:*PAK" +G'U
M-5B8$!*:J7FB\O&AJ,R&N26!SWB %]Z;U]ABG776W<E-:SC!LMV*/VB;(*03
M T#/R@06,BK #JZ*:+"#I^$BMP0A6BF  W**WZU@@5V+#23_P0HF'[64%ZXD
MX#[D5:=Y!PZ.EN)5RVN,5S7 GTT9BP?$@$5=5J<=A+4X"V7](\U P$$U8+4@
MP'XUG#G"RA0"2G0I(*M$ (:Q6@LJ' #8@-8IUB "!S&2RC[<'7?)6SU:E\[E
M8_FQQL)YY*J,5FQXP$E*BP-(&' LXY&%D/+!),WXRC/82GR57JR0(Z 0P >P
MG[3 VC6Y Y'%I*942C7:5,W9RBA:RP,\@[,,USIN"AE^$*:M9*@T7R"8F\X1
MI*P$ !3 '8/U5&^)!D\RI0%"&@3PW[1@6B9^P-Y1&FE,'3*."YQ57X5UQV@L
MF&4%0#B>BCO$QJTMS&!RBZ9%P+A,_T ,,%WO*1IU95E9_F!LS$.^:);LC:9J
M.(%H:%8%!8!:;HI 9)D(Z5QK! #Y08OK35F#F4-DBDJ=B4:D\);@Z66K)"9J
MCH8Z-J($,62608&N3%7+H%,@@-,*QF:G+ "O!9Y".0!T4@L\1%)K))<)SDH@
MG VPC48#0$$R3<L4TAJCQ."M^ J_\&2^="6U ,=N]19<NDH="@1,0@ 4].>K
MC!:HL0.5R1H8\J2M?)%JJD9O'5T;TN)J*0!,+B*!5HRY/( $1)P@*!HKO@H$
MK!8_C)WRN21.A=V#.2*@1!AV<LH_/ -ZZI.D_*:HE MO?!048!CKM9:FW.4S
MD1VLX"@ _/^DI*P6KN#DJ6@G#)G:\GV>JBW,U7EGB-G/@YY&IDP .3#H,V5D
MJM@C $ADIEPAKI0G&_K6/LB;_5TINSQ >WJ- @!+( [?:P6>?<J:=2%+D@;"
M5C[+/RQ7&X4HJX@7 !C !RC?* H"-_HHK@A"$$9+;<19['%<(-!D?@8"/^B<
M/%+?J[R&H_R7/)UG"R[H&2DIJ40J""F -701/("E;U'6*+(INW2-/CG'I$AC
M7F%J5^5FVT&G $#$;MC T0&DB<;%5/)ID=H/ NB<H,8**M;(*?(+ ["#!SB*
M()AJJHRHZT7 BVX*AOYJUUWGM:3GMT2+.X@1DME/ "" J()E(#3_P#]$P**F
M3,;LAN'YBHVJ2GRI52!4V#+-1K:0(Y0^B]CM!A?YBE!6RP=X*9V)$0!<@-=$
M@)G>RE<.V)Z%$, R5X9BH,,&'JXP+*P0JLU$'#35'+:B"CE<"DA>"Z:)1QQM
M;*<*0')U*\;5UVO4U[4T )R!5G75YP?(YR;B2I\^BW;*PSM(4JO"U<XVZZO$
MISLHFZRFA@2)K,UT#03H;#Y%4KZBBEZ9 S_0[*?T)<]>2P \PSM@[;60(_UA
MBTA>9D\AXVY=EM=\+;;<%FEE"_VY+;5(RA?AG,UTE[KX0]0&RMB2T]9F*X95
M$\S&2H\-KFHTP#YPZK04+K;\P^+"BLYM<TL#*(!QBHP'0$ !""G-Q&FW_0PZ
M&1[(ADP$H /0_0SI[AS0M)L$JHYG]2+0N(,$),'E8I7!N>ZO.&Z\3&$2'"[%
M+-\O1A7R)J_R+B_S-J_S/B_T1J_T3B_U5J_U7B_V9J_V;B_W=J_W?B_XAJ_X
'CB^K! 0 .P$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
